P2‐051: Can we afford not to screen for and treat HCV infection in Canada

首页> 外文期刊>Journal of viral hepatitis. >P2‐051: Can we afford not to screen for and treat HCV infection in Canada

【24h】

P2‐051: Can we afford not to screen for and treat HCV infection in Canada

机译：P2-051：我们是否可以在加拿大提供无筛选和治疗HCV感染

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Journal of viral hepatitis.》 |2018年第s1期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词

相似文献

外文文献
中文文献
专利

1. P2‐051: Can we afford not to screen for and treat HCV infection in Canada [J] . Journal of viral hepatitis. . 2018,第S1期

机译：P2-051：我们是否可以在加拿大提供无筛选和治疗HCV感染
2. P2‐153: Harm reduction coverage and risk of HCV infection: a comparison of HCV‐Na?ve and previously‐infected people who inject drugs [J] . Journal of viral hepatitis. . 2018,第S1期

机译：P2-153：损害降低覆盖率和HCV感染风险：HCV-NA？VE和以前感染的人注射毒品的比较
3. In-vitro problems of screening (Anti-HCV) and confirmatory tests (RIBA) for the diagnosis of HCV infections : The relation of neopterin and sCD14 with low Anti-HCV reactivity and different RIBA patterns [J] . B. Kocazeybek, Z. Habip, P. Sohrabi, International journal of infectious diseases : . 2016,第Supplementa1期

机译：诊断HCV感染的体外筛查（Anti-HCV）和确证试验（RIBA）问题：新蝶呤和sCD14与低抗HCV反应性和不同RIBA模式的关系
4. Safety of Peginterferon alfa-2a (PEGASYS) 180 mcg Weekly Plus Ribavirin (RBV) 800 mg Daily in HIV/HCV Coinfection Compared to HCV Monoinfection [C] . N. Brau, F.J. Torriani, M. Rodriguez Torres International AIDS Conference . 2004

机译：Peginterferon Alfa-2a（Pegasys）的安全性为180 mcg每周加上利韦韦林（RBV）800mg在HIV / HCV辛纤维中每日800毫克，与HCV单键相比
5. Blood-borne Viral Infections HBV, HCV, HIV – Occupational Risk and Prevention Among Nurses =Хемоконтактни вирусни инфекции – Хепатит В, С, СПИН – професионален риск и превенция сред медицинските сестри [D] . Dzhedzheva, Pepa. 2019

机译：血腥病毒感染HBV，HCV，艾滋病毒 - 护士中职业风险和预防=血液接触性病毒感染 - 乙型肝炎，C，艾滋病 - 护士中的专业风险和预防
6. HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs [O] . Rujipat Wasitthankasem, Preeyaporn Vichaiwattana, Chompoonut Auphimai, -1

机译：HCV核心抗原是HCV RNA的替代标记可用于评估活动性HCV感染：在可负担的DAA时代改善诊断选择的意义
7. HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs [O] . Rujipat Wasitthankasem, Preeyaporn Vichaiwattana, Chompoonut Auphimai, 2017

机译：HCV核心抗原是用于评估活动性HCV感染的HCV RNa的替代标志物：在经济实惠的Daa时代改善诊断选择的意义

P2‐051: Can we afford not to screen for and treat HCV infection in Canada

著录项

引文网络

相似文献

相关主题

期刊订阅